<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04129645</url>
  </required_header>
  <id_info>
    <org_study_id>URO-01</org_study_id>
    <nct_id>NCT04129645</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of URS Stents</brief_title>
  <official_title>Prospective Observational Study for Assessment of the Efficacy and Safety of Allium Ureteral Stent Long-term Indwelling in the Treatment of Ureteral Stricture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective observational study aimed to assess the efficacy and safety of Allium ureteral
      stent long-term indwelling in the treatment of ureteral stricture.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patency rate</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Number of patients evaluated with hydronephrosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Indwelling time</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Number of months of the implant in the ureter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device related serious adverse events</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Number of device related serious adverse events</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Ureteral Stricture</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>URS</intervention_name>
    <description>URS is a permanent ureteral stent made of nitinol and covered by a polymer, that is indicated to open strictures in the ureter.
Study patients who has strictures in the ureter, will be implanted with the URS for long term opening of the stricture.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from ureteral obstruction that require treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Benign diseases: UPJ, ischemic injury caused by surgical separation, endoscopic
             surgery injury, heat injury by laser lithotripsy, infection (chronic inflammation,
             tuberculosis), peri-ureteral fibrosis caused by endometriosis, ureteral anastomotic
             stenosis after renal transplantation, ureteral fistula, multiple polyps;

          2. Malignant diseases: ureteral anastomotic stricture after urinary diversion, stricture
             caused by compression of abdominal and/or pelvic tumors, stricture caused by urinary
             tract tumors, stricture caused by radiotherapy for colon or cervical cancer, ureteral
             fistula

        Exclusion Criteria:

          1. Combine with hypertonic neurogenic bladder (except for patients with long-term
             indwelling catheter)

          2. Colon resection surgery patients -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Weihong Feng</last_name>
    <phone>86-10-68946338</phone>
    <phone_ext>801</phone_ext>
    <email>fengwhr@139.com</email>
  </overall_contact>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 15, 2019</study_first_submitted>
  <study_first_submitted_qc>October 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2019</study_first_posted>
  <last_update_submitted>October 15, 2019</last_update_submitted>
  <last_update_submitted_qc>October 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Huhao</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>Ureteral</keyword>
  <keyword>ureteral stent</keyword>
  <keyword>ureteral stricture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

